The European makers of Ozempic for diabetes and Cetaphil for dry skin said they would feel an impact from President Donald ...

Trump administration officials say budget cuts are necessary to reduce federal spending, but experts warn of long-term implications for our health.

Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...

Insurance companies generally cover Ozempic and Wegovy when it is prescribed for Type 2 diabetes. However, when the drugs are ...

US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...

When Dr. Marty Makary, President Trump’s nominee as FDA commissioner ... the FDA declared an end to the shortage of another ...

Officials in Greenland and Denmark insist the world's largest island isn't for sale. Is President Donald Trump hearing them?